Literature DB >> 8691632

[Endoscopic treatment of gastrointestinal cancers--indication and limitation].

H Suzuki1, K Masuda, J Fujisaki, S Okuwaki.   

Abstract

Recently, endoscopic treatments have been applied for the curative treatment of early gastrointestinal cancers and for the palliative treatment of end-stage gastrointestinal cancers. As a curative treatment for early gastric cancers, the endoscopic Nd-YAG laser therapy was initially applied and a satisfactory results were obtained. However, the endoscopic mucosal resection (EMR) is evaluated as the reliable endoscopic treatment for early gastric cancers because curability can be histologically detected by resected specimen. EMR technique is also applied for early esophageal cancers and early flat or depressed colon cancers. EMR-L (EMR with the use of Ligating device) developed by us is mainly practiced in our department. By the use of EMR-L technique. Resectability has been improved compared with 2 channel EMR technique. As the palliation of end-stage gastrointestinal cancers endoscopy recanalization of malignant esophageal stenosis is very effective to improve the patient's QOL. The memorial metallic stent for esophageal stenosis is very useful to keep cavity for a long term after endoscopic recanalization. PEG (percutaneous endoscopic gastrostomy) is also very effective to reduce the symptoms of the patients with peritonitis carcinoma or ileus. In this paper, the present status of curative and palliative endoscopic treatment for gastrointestinal cancers was reported. In recent future, endoscopy will be more widely applied as a less invasive therapeutic procedure for gastrointestinal cancers.

Entities:  

Mesh:

Year:  1996        PMID: 8691632

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

1.  Endoscopic mucosal resection in the setting of Barrett's esophagus.

Authors:  Jason K Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

2.  Endoscopic mucosal resection: early experience in British Columbia.

Authors:  Mayur Brahmania; Eric Lam; Jennifer Telford; Robert Enns
Journal:  Can J Gastroenterol       Date:  2010-04       Impact factor: 3.522

3.  Efficacy and safety of 0.4 percent sodium hyaluronate for endoscopic submucosal dissection of gastric neoplasms.

Authors:  Young Dae Kim; Jun Lee; Ju Yeon Cho; Seok Won Kim; Seong Hwan Kim; Young Kwan Cho; Jin Seok Jang; Ji Sun Han; Joo Young Cho
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.